Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)

Launched by ORGANON AND CO · Aug 8, 2008

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • A subject must be 12 years of age or older, of either sex, and of any race.
• • A subject must have at least a 2-year history of SAR which exacerbates during the study season.
• • A subject must have a positive skin prick test response to an appropriate seasonal allergen at Visit 1.
• • A subject must be clinically symptomatic at the Screening and Baseline Visits.
• Exclusion Criteria:
• • A subject with a history of severe local reaction(s) or anaphylaxis to skin testing.
• • A subject who has had an upper respiratory tract or sinus infection that required antibiotic therapy without at least a 14-day washout prior to the Screening Visit, or who has had a viral upper respiratory infection within 7 days prior to the Screening Visit.
• • A subject who has used any drug in an investigational protocol in the 30 days prior to the Screening Visit.
• • A subject who is participating in any other clinical study.
• • A subject who is part of the staff personnel directly involved with this study.
• • A subject who is a family member (parent, spouse, or sibling) of the investigational study staff.
• • A female subject who is breast-feeding, pregnant, or intends to become pregnant.
• • A subject previously randomized into this study.
• • A subject who has a family member (parent, spouse, or sibling) currently enrolled in this study.